{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T16:48:42Z","timestamp":1762102122979},"reference-count":49,"publisher":"Spandidos Publications","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Mol Med Report"],"DOI":"10.3892\/mmr.2017.8252","type":"journal-article","created":{"date-parts":[[2017,12,11]],"date-time":"2017-12-11T13:34:52Z","timestamp":1512999292000},"source":"Crossref","is-referenced-by-count":3,"title":["Lower level of IL\u201135 and its reduced inhibition in Th17 cells in patients with bone marrow mononuclear cells Coombs test\u2011positive hemocytopenia"],"prefix":"10.3892","author":[{"given":"Yi","family":"Li","sequence":"first","affiliation":[{"name":"Department of Hematology, Tianjin Medical University General Hospital, Tianjin 300052, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yihao","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Hematology, Tianjin Medical University General Hospital, Tianjin 300052, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Hematology, Tianjin Medical University General Hospital, Tianjin 300052, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kai","family":"Ding","sequence":"additional","affiliation":[{"name":"Department of Hematology, Tianjin Medical University General Hospital, Tianjin 300052, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shanfeng","family":"Hao","sequence":"additional","affiliation":[{"name":"Department of Hematology, Tianjin Medical University General Hospital, Tianjin 300052, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuanyuan","family":"Shao","sequence":"additional","affiliation":[{"name":"Department of Hematology, Tianjin Medical University General Hospital, Tianjin 300052, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Honglei","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Hematology, Tianjin Medical University General Hospital, Tianjin 300052, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Hematology, Tianjin Medical University General Hospital, Tianjin 300052, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lei","family":"Huang","sequence":"additional","affiliation":[{"name":"Department of Hematology, Tianjin Medical University General Hospital, Tianjin 300052, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zonghong","family":"Shao","sequence":"additional","affiliation":[{"name":"Department of Hematology, Tianjin Medical University General Hospital, Tianjin 300052, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rong","family":"Fu","sequence":"additional","affiliation":[{"name":"Department of Hematology, Tianjin Medical University General Hospital, Tianjin 300052, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2017,12,11]]},"reference":[{"key":"key20200713223833_b1-mmr-17-02-2973","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1038\/nature06306","article-title":"The inhibitory cytokine IL-35 contributes to regulatory T-cell function","volume":"450","author":"Collison","year":"2007","journal-title":"Nature"},{"key":"key20200713223833_b2-mmr-17-02-2973","doi-asserted-by":"publisher","first-page":"3021","DOI":"10.1002\/eji.200737810","article-title":"IL-35 is a novel cytokine with therapeutic effects against collagen-induced arthritis through the expansion of regulatory T cells and suppression of Th17 cells","volume":"37","author":"Niedbala","year":"2007","journal-title":"Eur J Immunol"},{"key":"key20200713223833_b3-mmr-17-02-2973","doi-asserted-by":"publisher","first-page":"7144","DOI":"10.4049\/jimmunol.0902739","article-title":"IL-35 stimulation of CD39+ regulatory T cells confers protection against collagen II-induced arthritis via the production of IL-10","volume":"184","author":"Kochetkova","year":"2010","journal-title":"J Immunol"},{"key":"key20200713223833_b4-mmr-17-02-2973","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.cellimm.2015.01.013","article-title":"IgG autoantibody subclasses altered in immuno-related hemocytopenia","volume":"294","author":"Shao","year":"2015","journal-title":"Cell Immunol"},{"key":"key20200713223833_b5-mmr-17-02-2973","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1111\/cei.12347","article-title":"Distinguishing immunorelated haemocytopenia from idiopathic cytopenia of undetermined significance (ICUS): A bone marrow abnormality mediated by autoantibodies","volume":"177","author":"Fu","year":"2014","journal-title":"Clin Exp Immunol"},{"key":"key20200713223833_b6-mmr-17-02-2973","first-page":"236","article-title":"Quantity and apoptosis-related protein level of B lymphocyte in patients with immunorelated pancytopenia","volume":"23","author":"Fu","year":"2002","journal-title":"Zhonghua Xue Ye Xue Za Zhi"},{"key":"key20200713223833_b7-mmr-17-02-2973","first-page":"2989","article-title":"Quantity and function of regulatory T cells in hemocytopenic patients with positive BMMNC-Coombs test","volume":"90","author":"Fu","year":"2010","journal-title":"Zhonghua Yi Xue Za Zhi"},{"key":"key20200713223833_b8-mmr-17-02-2973","first-page":"684","article-title":"Study of the quantity and function of Th17 cells in the blood cytopenic patients with positive BMMNC-Coombs test","volume":"31","author":"Fu","year":"2010","journal-title":"Zhonghua Xue Ye Xue Za Zhi"},{"key":"key20200713223833_b9-mmr-17-02-2973","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.bcmd.2014.04.008","article-title":"Pilot study using tacrolimus rather than cyclosporine plus antithymocyte globulin as an immunosuppressive therapy regimen option for severe aplastic anemia in adults","volume":"53","author":"Zhu","year":"2014","journal-title":"Blood Cells Mol Dis"},{"key":"key20200713223833_b10-mmr-17-02-2973","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"key20200713223833_b11-mmr-17-02-2973","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1016\/j.leukres.2006.11.009","article-title":"Definitions and standards in the diagnosis and treatment of the myelodysplastic syndromes: Consensus statements and report from a working conference","volume":"31","author":"Valent","year":"2007","journal-title":"Leuk Res"},{"key":"key20200713223833_b12-mmr-17-02-2973","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1007\/s00277-009-0845-0","article-title":"Idiopathic neutropenia with fewer than 5% dysplasia may be a distinct entity of idiopathic cytopenia of undetermined significance","volume":"89","author":"Ando","year":"2010","journal-title":"Ann Hematol"},{"key":"key20200713223833_b13-mmr-17-02-2973","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1210\/endo.138.1.4846","article-title":"Prevention of spontaneous autoimmune diabetes in diabetes-prone BB rats by prophylactic treatment with antirat interferon-gamma antibody","volume":"138","author":"Nicoletti","year":"1997","journal-title":"Endocrinology"},{"key":"key20200713223833_b14-mmr-17-02-2973","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1046\/j.1365-2567.1999.00836.x","article-title":"Endogenous interleukin-12 only plays a key pathogenetic role in non-obese diabetic mouse diabetes during the very early stages of the disease","volume":"97","author":"Nicoletti","year":"1999","journal-title":"Immunology"},{"key":"key20200713223833_b15-mmr-17-02-2973","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1006\/cyto.1999.0561","article-title":"Essential pathogenetic role for interferon (IFN-)gamma in concanavalin A-induced T cell-dependent hepatitis: Exacerbation by exogenous IFN-gamma and prevention by IFN-gamma receptor-immunoglobulin fusion protein","volume":"12","author":"Nicoletti","year":"2000","journal-title":"Cytokine"},{"key":"key20200713223833_b16-mmr-17-02-2973","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1053\/jhep.2000.17701","article-title":"Murine concanavalin A-induced hepatitis is prevented by interleukin 12 (IL-12) antibody and exacerbated by exogenous IL-12 through an interferon-gamma-dependent mechanism","volume":"32","author":"Nicoletti","year":"2000","journal-title":"Hepatology"},{"key":"key20200713223833_b17-mmr-17-02-2973","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1002\/eji.1830230143","article-title":"The effects of a monoclonal antibody to interferon-gamma on experimental autoimmune thyroiditis (EAT): Prevention of disease and decrease of EAT-specific T cells","volume":"23","author":"Tang","year":"1993","journal-title":"Eur J Immunol"},{"key":"key20200713223833_b18-mmr-17-02-2973","doi-asserted-by":"publisher","first-page":"1933","DOI":"10.1002\/(SICI)1521-4141(199906)29:06<1933::AID-IMMU1933>3.0.CO;2-3","article-title":"The involvement of IL-12 in murine experimentally induced autoimmune thyroid disease","volume":"29","author":"Zaccone","year":"1999","journal-title":"Eur J Immunol"},{"key":"key20200713223833_b19-mmr-17-02-2973","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/1479-5876-10-19","article-title":"Gene silencing of IL-12 in dendritic cells inhibits autoimmune arthritis","volume":"10","author":"Li","year":"2012","journal-title":"J Transl Med"},{"key":"key20200713223833_b20-mmr-17-02-2973","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1080\/09674845.2016.1264704","article-title":"Potential route of Th17\/Treg cell dynamics in targeting type 1 diabetes and rheumatoid arthritis: An autoimmune disorder perspective","volume":"74","author":"Karri","year":"2017","journal-title":"Br J Biomed Sci"},{"key":"key20200713223833_b21-mmr-17-02-2973","doi-asserted-by":"publisher","first-page":"989","DOI":"10.3892\/ijmm.2013.1287","article-title":"Aberrant expression of circulating Th17, Th1 and Tc1 cells in patients with active and inactive ulcerative colitis","volume":"31","author":"Dong","year":"2013","journal-title":"Int J Mol Med"},{"key":"key20200713223833_b22-mmr-17-02-2973","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.jns.2013.03.002","article-title":"Role of Th17 cells in the pathogenesis of CNS inflammatory demyelination","volume":"333","author":"Rostami","year":"2013","journal-title":"J Neurol Sci"},{"key":"key20200713223833_b23-mmr-17-02-2973","doi-asserted-by":"publisher","first-page":"3685","DOI":"10.2147\/DDDT.S102141","article-title":"Ustekinumab in treatment of Crohn's disease: Design, development, and potential place in therapy","volume":"10","author":"Deepak","year":"2016","journal-title":"Drug Des Devel Ther"},{"key":"key20200713223833_b24-mmr-17-02-2973","doi-asserted-by":"publisher","first-page":"711","DOI":"10.3892\/ijmm.2013.1611","article-title":"Chimeric anti-IL-17 full-length monoclonal antibody is a novel potential candidate for the treatment of rheumatoid arthritis","volume":"33","author":"Bai","year":"2014","journal-title":"Int J Mol Med"},{"key":"key20200713223833_b25-mmr-17-02-2973","doi-asserted-by":"publisher","first-page":"229","DOI":"10.2217\/imt-2016-0128","article-title":"Secukinumab in the treatment of psoriasis: An update","volume":"9","author":"Reszke","year":"2017","journal-title":"Immunotherapy"},{"key":"key20200713223833_b26-mmr-17-02-2973","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1038\/ni.2366","article-title":"IL-12 family cytokines: Immunological playmakers","volume":"13","author":"Vignali","year":"2012","journal-title":"Nat Immunol"},{"key":"key20200713223833_b27-mmr-17-02-2973","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.cyto.2015.01.030","article-title":"Interleukin 12 (IL-12) family cytokines: Role in immune pathogenesis and treatment of CNS autoimmune disease","volume":"75","author":"Sun","year":"2015","journal-title":"Cytokine"},{"key":"key20200713223833_b28-mmr-17-02-2973","doi-asserted-by":"publisher","first-page":"315","DOI":"10.3389\/fimmu.2013.00315","article-title":"Interleukin 35: A key mediator of suppression and the propagation of infectious tolerance","volume":"4","author":"Olson","year":"2013","journal-title":"Front Immunol"},{"key":"key20200713223833_b29-mmr-17-02-2973","doi-asserted-by":"publisher","first-page":"713","DOI":"10.3892\/ijmm.2016.2688","article-title":"Effects of an intravitreal injection of interleukin-35-expressing plasmid on pro-inflammatory and anti-inflammatory cytokines","volume":"38","author":"Hou","year":"2016","journal-title":"Int J Mol Med"},{"key":"key20200713223833_b30-mmr-17-02-2973","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1007\/s10753-016-0453-9","article-title":"Interleukin-35: A potential therapeutic agent for autoimmune diseases","volume":"40","author":"Guan","year":"2017","journal-title":"Inflammation"},{"key":"key20200713223833_b31-mmr-17-02-2973","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1016\/j.cytogfr.2015.07.013","article-title":"Interleukin 35: Critical regulator of immunity and lymphocyte-mediated diseases","volume":"26","author":"Egwuagu","year":"2015","journal-title":"Cytokine Growth Factor Rev"},{"key":"key20200713223833_b32-mmr-17-02-2973","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1126\/science.1079490","article-title":"Control of regulatory T cell development by the transcription factor Foxp3","volume":"299","author":"Hori","year":"2003","journal-title":"Science"},{"key":"key20200713223833_b33-mmr-17-02-2973","doi-asserted-by":"publisher","first-page":"763","DOI":"10.3109\/02770903.2015.1038390","article-title":"A potential immunopathogenic role for reduced IL-35 expression in allergic asthma","volume":"52","author":"Wang","year":"2015","journal-title":"J Asthma"},{"key":"key20200713223833_b34-mmr-17-02-2973","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.cyto.2015.02.003","article-title":"IL-35 expression in peripheral blood CD4(+) T cells from chronic hepatitis B virus-infected patients directly correlates with virus load","volume":"73","author":"Zhou","year":"2015","journal-title":"Cytokine"},{"key":"key20200713223833_b35-mmr-17-02-2973","doi-asserted-by":"publisher","first-page":"121","DOI":"10.3892\/mmr.2014.2681","article-title":"Function of interleukin-17 and \u221235 in the blood of patients with hepatitis B-related liver cirrhosis","volume":"11","author":"Shi","year":"2015","journal-title":"Mol Med Rep"},{"key":"key20200713223833_b36-mmr-17-02-2973","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.3892\/ijmm.2014.1662","article-title":"Effects of phased joint intervention on IL-35 and IL-17 expression levels in patients with portal hypertension","volume":"33","author":"Wang","year":"2014","journal-title":"Int J Mol Med"},{"key":"key20200713223833_b37-mmr-17-02-2973","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1038\/ni.1952","article-title":"IL-35-mediated induction of a potent regulatory T cell population","volume":"11","author":"Collison","year":"2010","journal-title":"Nat Immunol"},{"key":"key20200713223833_b38-mmr-17-02-2973","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1007\/s10753-014-0038-4","article-title":"Aberrant expression of regulatory cytokine IL-35 and pattern recognition receptor NOD2 in patients with allergic asthma","volume":"38","author":"Wong","year":"2015","journal-title":"Inflammation"},{"key":"key20200713223833_b39-mmr-17-02-2973","first-page":"633","article-title":"Different doses of transforming growth factor-b on in vitro differentiation of human naive CD4+ T cells to T helper 17","volume":"14","author":"Ghaedi","year":"2015","journal-title":"Iran J Allergy Asthma Immunol"},{"key":"key20200713223833_b40-mmr-17-02-2973","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1038\/nature09447","article-title":"Generation of pathogenic T(H)17 cells in the absence of TGF-\u03b2 signalling","volume":"467","author":"Ghoreschi","year":"2010","journal-title":"Nature"},{"key":"key20200713223833_b41-mmr-17-02-2973","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1038\/ni.1613","article-title":"A critical function for transforming growth factor-beta, interleukin 23 and proinflammatory cytokines in driving and modulating human T(H)-17 responses","volume":"9","author":"Volpe","year":"2008","journal-title":"Nat Immunol"},{"key":"key20200713223833_b42-mmr-17-02-2973","doi-asserted-by":"publisher","first-page":"e1003628","DOI":"10.1371\/journal.ppat.1003628","article-title":"Epstein Barr virus-induced 3 (EBI3) together with IL-12 negatively regulates T helper 17-mediated immunity to Listeria monocytogenes infection","volume":"9","author":"Chung","year":"2013","journal-title":"PLoS Pathog"},{"key":"key20200713223833_b43-mmr-17-02-2973","doi-asserted-by":"crossref","unstructured":"PreskyDHYangHMinettiLJChuaAONabaviNWuCYGatelyMKGublerUA functional interleukin 12 receptor complex is composed of two beta-type cytokine receptor subunitsProc Natl Acad Sci USA931400214007199610.1073\/pnas.93.24.14002894305019484","DOI":"10.1073\/pnas.93.24.14002"},{"key":"key20200713223833_b44-mmr-17-02-2973","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1038\/ni.2227","article-title":"The composition and signaling of the IL-35 receptor are unconventional","volume":"13","author":"Collison","year":"2012","journal-title":"Nat Immunol"},{"key":"key20200713223833_b45-mmr-17-02-2973","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1556\/030.63.2016.1.1","article-title":"IL-12 family cytokines: General characteristics, pathogenic microorganisms, receptors, and signalling pathways","volume":"63","author":"Behzadi","year":"2016","journal-title":"Acta Microbiol Immunol Hung"},{"key":"key20200713223833_b46-mmr-17-02-2973","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1089\/jir.2010.0115","article-title":"Interleukin-27-mediated suppression of human Th17 cells is associated with activation of STAT1 and suppressor of cytokine signaling protein 1","volume":"31","author":"Liu","year":"2011","journal-title":"J Interferon Cytokine Res"},{"key":"key20200713223833_b47-mmr-17-02-2973","doi-asserted-by":"publisher","first-page":"4144","DOI":"10.4049\/jimmunol.1302246","article-title":"IL-27 induces Th17 differentiation in the absence of STAT1 signaling","volume":"195","author":"Peters","year":"2015","journal-title":"J Immunol"},{"key":"key20200713223833_b48-mmr-17-02-2973","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1111\/cei.12639","article-title":"Remission of systemic lupus erythematosus disease activity with regulatory cytokine interleukin (IL)-35 in Murphy Roths Large (MRL)\/lpr mice","volume":"181","author":"Cai","year":"2015","journal-title":"Clin Exp Immunol"},{"key":"key20200713223833_b49-mmr-17-02-2973","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1007\/s11033-016-4034-7","article-title":"Interleukin-35 (IL-35) inhibits proliferation and promotes apoptosis of fibroblast-like synoviocytes isolated from mice with collagen-induced arthritis","volume":"43","author":"Li","year":"2016","journal-title":"Mol Biol Rep"}],"container-title":["Molecular Medicine Reports"],"original-title":[],"deposited":{"date-parts":[[2020,7,13]],"date-time":"2020-07-13T22:40:08Z","timestamp":1594680008000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.spandidos-publications.com\/10.3892\/mmr.2017.8252"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12,11]]},"references-count":49,"URL":"https:\/\/doi.org\/10.3892\/mmr.2017.8252","relation":{},"ISSN":["1791-2997","1791-3004"],"issn-type":[{"value":"1791-2997","type":"print"},{"value":"1791-3004","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,12,11]]}}}